Member Info for SGD27

Yes the spread is terrible, reflecting the illiquidity. So little interest here despite all their attempts at publicity, interviews etc. Perhaps this event on Thursday will help :

https://www.proactiveinvestors.co.uk/register/event_details/250

Of course an under-the-radar share can sometimes be an opportunity.

I see the Imara SP rise seems to be holding quite well.

Thanks :-)

@ChrisToffer 17:12 "the presentation that was released last week"

What was that referring to please?

If you're referring to the trades at ~08:45, notice that they're in pairs, and the value is ~£20k, so Bed&ISA or similar, surely.

... or of course, sells cunningly disguised to look like Bed&ISAs ;-)

@LiveLongnProsper : Thanks, yes, if I'd thought about it I would have added my find to your thread - so I'm resurrecting it now instead :-)

Any super-keen researchers might want to put this June 18 webinar in their diary :

https://www.humanvaccinesproject.org/event/june-11th-global-virus-outbreaks-interferons-as-1st-responders/

The Acacia deal is done. They're not saying which specific stocks were involved though.

https://equityincome.linkfundsolutions.co.uk/media/rocjnpk5/q-a-regarding-healthcare-assets-sale-05-june-2020.pdf

Thanks lignumvitae - that really is impressive! Now accounts for circa 50p per arix share on its own.

I think Benjamin Graham might have invested here :-)

I can't help noticing that 31,363,636 = £34,500 / 0.11p.

DYOR ;-)

https://www.investorschronicle.co.uk/shares/2020/06/04/hummingbird-farms-out-stake-in-dugbe-gold-project/

"
Tip Update: Buy at 28.5p
...
IC View
Hummingbird's shares dropped 4 per cent after this news came out. This is possibly because now seems to be a perfect time to borrow, with interest rates low and cash flowing in from Yanfolila, or that the related-party arrangement also sees directors take a separate stake in a Hummingbird project. However the deal is arranged, our buy recommendation is based on Yanfolila, and its production and expansion prospects. Buy.

Last IC View: Buy, 22.7p, 5 Mar 2020
"

An interesting large trade (sell?) from yesterday has appeared :

03-Jun-20 14:49:18 0.125 31,363,636 Unknown* 0.12 0.13 39.20k O

That's just under 1%.

https://www.vo%78markets.co.uk/articles/arix-bioscience-and-vadim-alexandre-on-novacyt-genedrive-omega-diagnostics-avacta-7868bf2

@phoenix41 : Thanks for the links. Hint - use lower case "https" to get them to work properly :-)

https://onenucleus.com/transcrip-providing-support-synairgen-confirms-commencement-dosing-trial-sng001-covid-19

I think crl123 is suggesting they're trying to scam pis
;-)

https://www.thisismoney.co.uk/money/investing/article-8383967/Reports-buyer-Woodfords-biotech-holdings-emerge.html

https://www.covidtrialathome.com/screening

"Do you live within approximately 40 miles of Southampton General Hospital, excluding the Isle of Wight?"

Hi Dubliner, credit to you for your prescience on larger scale customer trials as a gentle route to production.

But now out of the blue we have this hint about a return to PM drilling. Do you think they might be considering a sale of CS, keeping SRES as an exploration company rather than transitioning to a production company? If so, I hope it would generate a hefty special dividend, not just all be ploughed back into exploration. Another possibility would be fissioning SRES into two companies, one for production + one for exploration. Any thoughts?

Hi Richemondo, That's obviously been prompted by rising PM prices. The gold/silver ratio has come down a bit, but is still historically very high, so if it comes down more then yes, Bay State Silver may be the obvious project to resurrect.

More dissing of the remdesivir trial :

https://emcrit.org/pulmcrit/remdesivir-5-10/

They may have been on the placebo of course.